Mycobacterium avium hominissuis

Mycobacterium alvei
Scientific classification
Domain:
Phylum:
Class:
Order:
Family:
Genus:
Species:
Subspecies:
"M. a. hominissuis"
Trinomial name
"Mycobacterium avium hominissuis"

"Mycobacterium avium hominissuis" (M. avium) belongs to the genus Mycobacterium of the phylum Actinobacteria (one of the dominant phyla of bacteria).[1] Actinobacteria are characterized by a gram-positive cell wall with a high guanine and cytosine content.[2] Although M. avium is gram-positive, it shares features with gram-negative bacteria such as an "outer permeability barrier acting as a psuedo-outer membrane."[3]

M. avium hominissuis is a subspecies of the genus Mycobacterium thus its cell wall composition includes mycolic acids. Importantly, the mycolyl-arabinogalactan-peptidogylcan (mAGP) complex of the cell wall is composed of these aforementioned mycolic acids.[4] This specific composition leads to increased virulence and infection rates.[5]

M. avium is found in the environment: soil, water, dust, etc. and is typically spread via ingestion.[6] There is additional speculation that it's transmitted from human to human. This phenomenon has been observed in hospitals with cystic fibrosis patients.[7]

Non-Tuberculosis Mycobacteria (NTM)

M. avium hominissuis is a non-tuberculosis Mycobacteria (NTM). Like other Mycobacteria, NTMs are opportunistic pathogens - they cause illness in people with suppressed immune systems more than they infect people with healthy immune systems.[8] A well-known species of Mycobacterium is M. Tuberculosis which is responsible for tuberculosis (TB) infections. In 2023, TB globally caused illness in 10.8 million people and the subsequent deaths of 1.25 million people.[9]

While in the same genus as M. tuberculosis, M. avium isn't considered a tuberculosis bacterium. But, as an NTM it does cause infection. Specifically, M. avium takes advantage of diseased and weakened lung tissue as found in conditions like cystic fibrosis (CF). Once in the immune system, M. avium can cause pulmonary (lung) infections. This phenomenon can be seen in the infection rates of those with chronic lung diseases like CF. In 2023, 10% of CF patients in the U.S. tested positive for a NTM infection.[10]

Taxa Designation

Based on differences in IS1245 RFLP, 16S-23S rDNA ITS and growth temperature, Mijs et al. 2002.[11] propose to reserve the designation of Mycobacterium avium subsp. avium for bird-type isolates.

These authors suggest, but don't formally propose, that the designation of Mycobacterium avium subsp. hominissuis be strictly for isolates originating from humans and pigs. The suggested name for Mycobacterium avium hominissuis reflects its origin of humans and pigs.

References

  1. ^ PubChem. "Mycobacterium avium". pubchem.ncbi.nlm.nih.gov. Retrieved 2025-05-18.
  2. ^ De Simeis, Davide; Serra, Stefano (2021-04-22). "Actinomycetes: A Never-Ending Source of Bioactive Compounds—An Overview on Antibiotics Production". Antibiotics. 10 (5): 483. doi:10.3390/antibiotics10050483. ISSN 2079-6382. PMC 8143475. PMID 33922100.
  3. ^ Alderwick, Luke J.; Harrison, James; Lloyd, Georgina S.; Birch, Helen L. (2015-08-01). "The Mycobacterial Cell Wall—Peptidoglycan and Arabinogalactan". Cold Spring Harbor Perspectives in Medicine. 5 (8): a021113. doi:10.1101/cshperspect.a021113. ISSN 2157-1422. PMC 4526729. PMID 25818664.
  4. ^ Shetye, Gauri S.; Franzblau, Scott G.; Cho, Sanghyun (June 2020). "New tuberculosis drug targets, their inhibitors, and potential therapeutic impact". The Journal of Laboratory and Clinical Medicine. 220: 68–97. doi:10.1016/j.trsl.2020.03.007. PMID 32275897.
  5. ^ Nataraj, Vijayashankar; Varela, Cristian; Javid, Asma; Singh, Albel; Besra, Gurdyal S.; Bhatt, Apoorva (2015). "Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus". Molecular Microbiology. 98 (1): 7–16. doi:10.1111/mmi.13101. ISSN 1365-2958. PMC 4949712. PMID 26135034.
  6. ^ Busatto, Caroline; Vianna, Júlia Silveira; da Silva, Lande Vieira; Ramis, Ivy Bastos; da Silva, Pedro Eduardo Almeida (2019-01-01). "Mycobacterium avium: an overview". Tuberculosis. 114: 127–134. doi:10.1016/j.tube.2018.12.004. ISSN 1472-9792. PMID 30711152.
  7. ^ Azar, Michelle; Zimbric, Madsen; Shedden, Kerby; Caverly, Lindsay J. (2020-03-01). "Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis". Journal of Cystic Fibrosis. 19 (2): 232–235. doi:10.1016/j.jcf.2019.07.007. ISSN 1569-1993. PMC 7002288. PMID 31399327.
  8. ^ "What is an Opportunistic Infection? | NIH". hivinfo.nih.gov. Retrieved 2025-05-18.
  9. ^ "Tuberculosis (TB)". www.who.int. Retrieved 2025-05-18.
  10. ^ Wiesel, Vered; Aviram, Micha; Mei-Zahav, Meir; Dotan, Miri; Prais, Dario; Cohen-Cymberknoh, Malena; Gur, Michal; Bar-Yoseph, Ronen; Livnat, Galit; Goldbart, Aviv; Hazan, Guy; Hazan, Itai; Golan-Tripto, Inbal (2024-01-01). "Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study". Journal of Cystic Fibrosis. 23 (1): 41–49. doi:10.1016/j.jcf.2023.05.003. ISSN 1569-1993. PMID 37173154.
  11. ^ Mijs W, de Haas P, Rossau R, et al. (September 2002). "Molecular evidence to support a proposal to reserve the designation Mycobacterium avium subsp. avium for bird-type isolates and M. avium subsp. hominissuis for the human/porcine type of M. avium". Int. J. Syst. Evol. Microbiol. 52 (Pt 5): 1505–18. doi:10.1099/00207713-52-5-1505. PMID 12361252.
Prefix: a b c d e f g h i j k l m n o p q r s t u v w x y z 0 1 2 3 4 5 6 7 8 9

Portal di Ensiklopedia Dunia

Kembali kehalaman sebelumnya